MassMutual Private Wealth & Trust FSB boosted its stake in MetLife, Inc. (NYSE:MET – Free Report) by 16.1% in the 2nd quarter, according to its most recent filing with the SEC. The fund owned 2,891 shares of the financial services provider’s stock after purchasing an additional 400 shares during the period. MassMutual Private Wealth & Trust FSB’s holdings in MetLife were worth $232,000 at the end of the most recent quarter.
Several other institutional investors have also modified their holdings of MET. Ball & Co Wealth Management Inc. acquired a new position in shares of MetLife in the fourth quarter worth $25,000. North Capital Inc. acquired a new position in MetLife in the first quarter valued at $26,000. Motco increased its stake in MetLife by 105.5% in the first quarter. Motco now owns 413 shares of the financial services provider’s stock valued at $33,000 after purchasing an additional 212 shares during the period. WPG Advisers LLC acquired a new position in shares of MetLife during the first quarter worth about $46,000. Finally, American National Bank & Trust grew its position in MetLife by 128.4% during the first quarter. American National Bank & Trust now owns 603 shares of the financial services provider’s stock worth $48,000 after buying an additional 339 shares during the period. Institutional investors and hedge funds own 94.99% of the company’s stock.
MetLife Price Performance
NYSE MET opened at $79.13 on Friday. The stock has a market cap of $52.62 billion, a price-to-earnings ratio of 13.41, a PEG ratio of 0.71 and a beta of 0.87. MetLife, Inc. has a 52-week low of $65.21 and a 52-week high of $89.05. The business has a 50 day simple moving average of $78.27 and a 200 day simple moving average of $78.17. The company has a debt-to-equity ratio of 0.57, a quick ratio of 0.16 and a current ratio of 0.16.
MetLife Announces Dividend
The business also recently declared a quarterly dividend, which was paid on Tuesday, September 9th. Investors of record on Tuesday, August 5th were given a $0.5675 dividend. The ex-dividend date was Tuesday, August 5th. This represents a $2.27 dividend on an annualized basis and a dividend yield of 2.9%. MetLife’s dividend payout ratio (DPR) is presently 38.47%.
Analysts Set New Price Targets
A number of brokerages recently issued reports on MET. Barclays raised their target price on shares of MetLife from $88.00 to $94.00 and gave the stock an “overweight” rating in a research report on Monday, July 7th. UBS Group decreased their price target on shares of MetLife from $94.00 to $91.00 and set a “buy” rating for the company in a report on Thursday, August 7th. Keefe, Bruyette & Woods cut their price objective on shares of MetLife from $94.00 to $92.00 and set an “outperform” rating on the stock in a research report on Monday, August 11th. JPMorgan Chase & Co. boosted their price target on shares of MetLife from $86.00 to $95.00 and gave the stock an “overweight” rating in a research report on Tuesday, July 8th. Finally, Jefferies Financial Group lifted their price objective on shares of MetLife from $100.00 to $103.00 and gave the stock a “buy” rating in a research note on Monday, August 11th. One analyst has rated the stock with a Strong Buy rating, ten have issued a Buy rating and one has issued a Hold rating to the company. According to data from MarketBeat.com, the stock currently has a consensus rating of “Buy” and a consensus price target of $95.55.
Read Our Latest Analysis on MetLife
MetLife Company Profile
MetLife, Inc, a financial services company, provides insurance, annuities, employee benefits, and asset management services worldwide. It operates through six segments: Retirement and Income Solutions; Group Benefits; Asia; Latin America; Europe, the Middle East and Africa; and MetLife Holdings. The company offers life, dental, group short-and long-term disability, individual disability, pet insurance, accidental death and dismemberment, vision, and accident and health coverages, as well as prepaid legal plans; administrative services-only arrangements to employers; and general and separate account, and synthetic guaranteed interest contracts, as well as private floating rate funding agreements.
Read More
- Five stocks we like better than MetLife
- What is a Low P/E Ratio and What Does it Tell Investors?
- Why Seagate Is Wall Street’s New Favorite AI Infrastructure Play
- 3 Grocery Stocks That Are Proving They Are Still Essential
- 3 AI Infrastructure Stocks With Upside After the Summer Rally
- Stock Market Sectors: What Are They and How Many Are There?
- Can Advantage2 Help Overcome D-Wave’s Share Price Plateau?
Want to see what other hedge funds are holding MET? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for MetLife, Inc. (NYSE:MET – Free Report).
Receive News & Ratings for MetLife Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for MetLife and related companies with MarketBeat.com's FREE daily email newsletter.